Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Colcher

Showing results (71-80 of 140) with videos related to

Pageof 14
Sort By:
International Journal of Cancer|September 15, 1990
CA 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markersP Ferroni, C Szpak, J W Greiner, et al.
Cancer Research|January 13, 2001
Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic applicationA Goel, D Colcher, J Baranowska-Kortylewicz, et al.
Acta Radiologica. Supplementum|January 1, 1990
Binding of radiolabeled MAb B72.3 administered intravenously and intraperitoneally in colorectal cancer patients. An overviewJ Schlom, K Siler, D Colcher, et al.
Cancer Research|August 15, 1990
Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodiesM Kuroki, P D Fernsten, D Wunderlich, et al.
Cancer Research|June 1, 1986
Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancerD F Hayes, M R Zalutsky, W Kaplan, et al.
Cancer Research|March 1, 1992
Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugatesJ Schlom, D Eggensperger, D Colcher, et al.
Clinical Lymphoma|January 10, 2002
Feasibility and safety of outpatient Bexxar therapy (tositumomab and iodine I 131 tositumomab) for non-Hodgkin's lymphoma based on radiation doses to family membersF J Rutar, S C Augustine, M S Kaminski, et al.
Cancer Research|February 1, 1983
Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferationD W Kufe, L Nadler, L Sargent, et al.
Journal of Clinical Immunology|January 1, 1997
Antiidiotypic response against murine monoclonal antibodies reactive with tumor-associated antigen TAG-72I Blanco, R Kawatsu, K Harrison, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Conformationally biased analogs of human C5a mediate changes in vascular permeabilityR Kawatsu, S D Sanderson, I Blanco, et al.
Pageof 14

Showing results (71-80 of 140) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|September 15, 1990
CA 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markersP Ferroni, C Szpak, J W Greiner, et al.
Cancer Research|January 13, 2001
Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic applicationA Goel, D Colcher, J Baranowska-Kortylewicz, et al.
Acta Radiologica. Supplementum|January 1, 1990
Binding of radiolabeled MAb B72.3 administered intravenously and intraperitoneally in colorectal cancer patients. An overviewJ Schlom, K Siler, D Colcher, et al.
Cancer Research|August 15, 1990
Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodiesM Kuroki, P D Fernsten, D Wunderlich, et al.
Cancer Research|June 1, 1986
Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancerD F Hayes, M R Zalutsky, W Kaplan, et al.
Cancer Research|March 1, 1992
Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugatesJ Schlom, D Eggensperger, D Colcher, et al.
Clinical Lymphoma|January 10, 2002
Feasibility and safety of outpatient Bexxar therapy (tositumomab and iodine I 131 tositumomab) for non-Hodgkin's lymphoma based on radiation doses to family membersF J Rutar, S C Augustine, M S Kaminski, et al.
Cancer Research|February 1, 1983
Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferationD W Kufe, L Nadler, L Sargent, et al.
Journal of Clinical Immunology|January 1, 1997
Antiidiotypic response against murine monoclonal antibodies reactive with tumor-associated antigen TAG-72I Blanco, R Kawatsu, K Harrison, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Conformationally biased analogs of human C5a mediate changes in vascular permeabilityR Kawatsu, S D Sanderson, I Blanco, et al.
Pageof 14